Kiniksa Pharmaceuticals International

KNSANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.096 B

$78.13 +1.15%

Close of 21 Sept 2026

Revenue

$677.6M

#1751 by revenue

Earnings

$59.0M

#1504 by earnings

Shares outstanding

—

Latest filing cover page

P/E ratio

103.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#45Belite BioBLTE$6.98B
#46Rhythm PharmaceuticalsRYTM$6.80B
#47Kiniksa Pharmaceuticals InternationalKNSA$6.10B
#48Mirum PharmaceuticalsMIRM$5.97B
#49LiquidiaLQDA$5.95B

What if Kiniksa Pharmaceuticals International were worth as much as…

Open the what-if tool →

Gold $30.3T

$388,009.45

Per share 4,966× higher

Bitcoin $1.72T

$22,041.98

Per share 282× higher

Nvidia $5.48T

$70,232.97

Per share 899× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Kiniksa Pharmaceuticals International are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.